These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5306738)

  • 21. Combined treatment of leukaemias and reticuloses.
    Lancet; 1970 Oct; 2(7676):757-8. PubMed ID: 4195983
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
    Pouillart R; Huong TH; Brugerie E; Lheritier J
    Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of a multicentre study of the treatment of acute lymphoblastic leukaemia in adolescents and adults (1978-1981).
    Willemze R; Haanen C; Dekker A; Sizoo W; Abels J; Tricot G; Kerkhofs H; von dem Borne A; Kurstjens R; Roozendaal KJ; Goudsmit R
    Neth J Med; 1982; 25(9):303-7. PubMed ID: 6757770
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
    Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
    Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V; Kochupillai V
    J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclic drug regimen for acute childhood leukaemia.
    Lancet; 1968 Feb; 1(7538):313-8. PubMed ID: 4170155
    [No Abstract]   [Full Text] [Related]  

  • 31. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo.
    Chello PL; Sirotnak FM; Dorick DM
    Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of priming dose schedules in methotrexate treatment of mouse leukemia L1210.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1971 Oct; 31(10):1429-33. PubMed ID: 5095131
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetics of cancer cell kill by chemotherapeutic agents in vivo.
    Wilcox WS
    Natl Cancer Inst Monogr; 1967 Feb; 24():257-69. PubMed ID: 6021080
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The time factor in cancer chemotherapy.
    Mathé G; Schneider M; Schwarzenberg L
    Eur J Cancer (1965); 1970 Feb; 6(1):23-31. PubMed ID: 5416162
    [No Abstract]   [Full Text] [Related]  

  • 37. Identical efficacy of methotrexate regimens with N5-methyltetrahydrofolate rescue or with leucovorin rescue for treatment of L1210 murine leukemia.
    Nixon PF; Wilson L
    Cancer Treat Rep; 1983 Jan; 67(1):59-62. PubMed ID: 6604578
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in the chemotherapy sensitivity of leukemia L1210 cells during the development of diazan resistance].
    Goncharova SA; Shevtsova VN; Demidova NS; Konovalova NP
    Eksp Onkol; 1985; 7(3):56-9. PubMed ID: 4017934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.